Celltrion Data Supports Subcutaneous Remisma For IBD

Also Backs Biosimilar For Crohn’s Disease And Ulcerative Colitis

 
• By Dave Wallace
  
IBD_Syringe
Celltrion’s Data Supports Using Subcutaneous Infliximab Biosimilar For IBD • Source: Shutterstock

More from Biosimilars

More from Products